Moxifloxacine Eg (Moxifloxacin Hydrochloride)

Moxifloxacine Eg is a fluoroquinolone antibiotic indicated for several bacterial infections.

• Community‑acquired bacterial pneumonia: eradicates the causative pathogens and improves respiratory function.
• Acute bacterial sinusitis: reduces sinus inflammation by eliminating the infecting bacteria.
• Acute bacterial exacerbations of chronic bronchitis: helps restore airway clearance and reduces symptom severity.
• Skin and skin structure infections: treats susceptible Gram‑positive and Gram‑negative organisms to promote wound healing.

• Moxifloxacin inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA replication, transcription, and repair. By stabilizing the enzyme‑DNA complex, it prevents the resealing of DNA strands, leading to accumulation of double‑strand breaks and bacterial cell death. This bactericidal action is effective against a broad spectrum of Gram‑positive and Gram‑negative organisms.

Moxifloxacine Eg may cause adverse reactions that vary in frequency and severity.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Diarrhea: loose stools that may be self‑limiting.
• Headache: transient cranial discomfort.
• Rash: mild skin erythema or itching.

Serious or Rare Side Effects

• Tendon rupture: sudden pain and loss of function, especially in the Achilles tendon.
• QT interval prolongation: risk of cardiac arrhythmias.
• Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome.
• Clostridioides difficile infection: severe colitis requiring medical attention.

Before prescribing Moxifloxacine Eg, clinicians should consider several safety measures.

• Assess renal function: adjust therapy in patients with impaired clearance.
• Monitor for tendon pain: discontinue if signs of tendonitis or rupture appear.
• Check cardiac status: avoid in patients with known QT prolongation or electrolyte disturbances.
• Avoid use in patients with documented hypersensitivity to fluoroquinolones.
• Store at ambient temperature: keep in the original container, protect from moisture and light.

Moxifloxacine Eg can interact with other medicines, requiring careful management.

Major Interactions (Avoid)

• Antacids containing magnesium or aluminum: reduce absorption of the antibiotic.
• Warfarin: may increase anticoagulant effect and bleeding risk.
• Cyclosporine: elevated cyclosporine concentrations can lead to toxicity.

Moderate Interactions (Monitor Closely)

• NSAIDs: combined use may raise the risk of central nervous system stimulation.
• Corticosteroids: concurrent therapy can increase the chance of tendon rupture.
• Theophylline: may raise plasma levels, necessitating dose adjustment.